IL6 and breast carcinoma: As IL6 had been shown to be a pleiotropic cytokine with both tumor-promoting and inhibitory activity [33], the up-regulation of the expression of IL6 mRNA in the SN-F11/12-treated MDA-MB-231 cells may cause an inhibitory effect to the growth of the breast cancer cell line.